Roche, the manufacturer of Tamiflu, has made it impossible for scientists to assess how well the anti-flu drug works by withholding the evidence the company has gained from trials, doctors alleged on Tuesday.
A major review of what data there is in the public domain has found no evidence Tamiflu can prevent healthy people with flu from suffering complications such as pneumonia.
Tamiflu may shorten the bout of illness by a day or so, the investigators say, but it is impossible to know whether it prevents severe disease because the published data is insufficient. Roche has failed to make some of the studies carried out on the drug publicly available, the scientists say.
“Governments around the world have spent billions of pounds on a drug that the scientific community now finds itself unable to judge,” said Fiona Godlee, editor of the British Medical Journal, which published the new review online and collaborated in a joint investigation with Channel 4 News, shown on Tuesday night.
Roche has made a fortune out of the drug, with sales of £1.6 billion this year alone.
In the review, Chris Del Mar, from Bond University in Australia, analyzed 20 published trials that focused on prevention, treatment and adverse reactions. The authors say they were hampered by the “paucity of good data.”
The reviewers were forced to leave out eight trials because they had not been published, and Roche offered them “under conditions we thought unacceptable, and what was offered to us was insufficient to analyze properly.”
As they did not have full access to all the trials, the reviewers say previous evidence on the effects of Tamiflu and other drugs of this class [the neuraminidase inhibitors] may be unreliable. They call on governments to set up studies to monitor the drugs for safety.
A second review was carried out at Birmingham University, England, by Nick Freemantle and Melanie Calvert, who analyzed a series of observational studies Roche provided. These are studies of people who took the drugs, but without a comparison group of people who did not take them.
Although the reviewers had doubts about the data, they say it is possible Tamiflu reduced the risk of pneumonia. But if so, the benefit was small and there were side-effects to consider.
Freemantle said he saw “very little evidence to support the widespread use of oseltamivir in the otherwise healthy population who are developing signs of influenza-like illness.”
He added: “We have remarkably few resources in this country [the UK] to spend on pharmaceuticals on health, and it is surprising to see such widespread use of oseltamivir. But I suppose that once you’ve gone and bought lots of doses, then it’s a bit like the situation with gun control in the US. If you have a gun in the house, it is much easier to use it. But it does not mean it’s the right thing to do.”
Godlee and Mike Clarke, director of the UK Cochrane Centre, call, in the BMJ, for new global legislation to ensure all trial data on drugs that have been granted a licence must be published in full.
Roche said that it firmly believed in the robustness of the data. It said governments and licensing authorities had been given access to all the trial information.
Roche has now undertaken to put summaries of all the Tamiflu study data on a password-protected site.
Archeologists in Peru on Thursday said they found the 5,000-year-old remains of a noblewoman at the sacred city of Caral, revealing the important role played by women in the oldest center of civilization in the Americas. “What has been discovered corresponds to a woman who apparently had elevated status, an elite woman,” archeologist David Palomino said. The mummy was found in Aspero, a sacred site within the city of Caral that was a garbage dump for more than 30 years until becoming an archeological site in the 1990s. Palomino said the carefully preserved remains, dating to 3,000BC, contained skin, part of the
‘WATER WARFARE’: A Pakistani official called India’s suspension of a 65-year-old treaty on the sharing of waters from the Indus River ‘a cowardly, illegal move’ Pakistan yesterday canceled visas for Indian nationals, closed its airspace for all Indian-owned or operated airlines, and suspended all trade with India, including to and from any third country. The retaliatory measures follow India’s decision to suspend visas for Pakistani nationals in the aftermath of a deadly attack by shooters in Kashmir that killed 26 people, mostly tourists. The rare attack on civilians shocked and outraged India and prompted calls for action against their country’s archenemy, Pakistan. New Delhi did not publicly produce evidence connecting the attack to its neighbor, but said it had “cross-border” links to Pakistan. Pakistan denied any connection to
TRUMP EFFECT: The win capped one of the most dramatic turnarounds in Canadian political history after the Conservatives had led the Liberals by more than 20 points Canadian Prime Minister Mark Carney yesterday pledged to win US President Donald Trump’s trade war after winning Canada’s election and leading his Liberal Party to another term in power. Following a campaign dominated by Trump’s tariffs and annexation threats, Carney promised to chart “a new path forward” in a world “fundamentally changed” by a US that is newly hostile to free trade. “We are over the shock of the American betrayal, but we should never forget the lessons,” said Carney, who led the central banks of Canada and the UK before entering politics earlier this year. “We will win this trade war and
Armed with 4,000 eggs and a truckload of sugar and cream, French pastry chefs on Wednesday completed a 121.8m-long strawberry cake that they have claimed is the world’s longest ever made. Youssef El Gatou brought together 20 chefs to make the 1.2 tonne masterpiece that took a week to complete and was set out on tables in an ice rink in the Paris suburb town of Argenteuil for residents to inspect. The effort overtook a 100.48m-long strawberry cake made in the Italian town of San Mauro Torinese in 2019. El Gatou’s cake also used 350kg of strawberries, 150kg of sugar and 415kg of
RSS